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INTRODUCTION:  Choriocarcinoma  is  a highly  malignant  trophoblastic  neoplasm.  Its  association  with
ectopic  pregnancy  is  very  rare  and  usually  with  aggressive  behavior.
PRESENTATION  OF CASE:  We  report  a  new  case  arising  in  an interstitial  pregnancy  occurring  in a  46-year-
old  woman.  The  patient  was  admitted  for severe  pelvic  pain  and  abundant  metrorrhagia.  One  month  ago,
she  had  had  a laparoscopic  resection  of  an  interstitial  pregnancy  subsequent  to  failure  of  chemotherapy  by
methotrexate.  The  raise  of serum  hCG  level  and  the  hyperechoic  intrauterine  mass  were in favor  of ges-
tational  trophoblastic  disease.  Urgent  laparotomy  was  performed  for circulatory  collapse.  Hysterectomy
was done.  Histological  examination  revealed  a choriocarcinoma.  The  patient  underwent  chemotherapy.
Two  years  later,  neither  metastasis  nor  recurrence  was  detected.
DISCUSSION:  Clinical  diagnosis  of  primary  interstitial  choriocarcinoma  is  difﬁcult,  since  it is  rare  and
manifesting  by  non-speciﬁc  abnormal  vaginal  bleeding.  Imaging  ﬁndings  are  also  not  helpful  in ectopic
location.  The  frequency  of  metastasis  is related  to the  delayed  diagnosis.  Serial  measurement  of  hCG
level  was the  most  useful  marker  of  diagnosis  and follow  up.  Histopathological  examination  remains  the
only tool  of the  precise  diagnosis.  Choriocarcinoma  has a very  good  prognosis  even  in advanced  stages,
since  it  is very  chemosensitive.
CONCLUSION:  The  current  trend  of  the  treatment  of  ectopic  pregnancy  by conservative  surgery  requires
adequate  monitoring  of hCG  and careful  examination  of pathologic  specimens  to  avoid  misdiagnosis  of
ectopic  gestational  trophoblastic  disease.
©  2014  The  Authors.  Published  by Elsevier  Ltd.  on behalf  of  Surgical  Associates  Ltd.  This  is  an  open
he  CCaccess  article  under  t
. Introduction
Choriocarcinoma is a rare malignant gestational trophoblastic
umor. Although it is most commonly due to malignant trans-
ormation of a molar pregnancy, it can develop after all types of
regnancy including normal term pregnancy, spontaneous abor-
ion or ectopic pregnancy.1 However, choriocarcinoma arising in
ctopic pregnancy is an extremely rare event. Its incidence is
ne in 5333 tubal pregnancies and one in 1.6 million normal
ntrauterine pregnancies.1 To our knowledge, two  cases of chorio-
arcinoma arising in an interstitial pregnancy were reported in the
iterature.2,3 We  report here a new case.
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2. Case report
A 46-year-old woman, gravida 4, para 3, was  admitted for
abdominal pain. She had had an amenorrhea of 7 weeks. Physical
examination revealed severe right adnexal pain and tenderness.
Transvaginal sonography showed an empty uterus with a thin
endometrium and a 3 cm intramural echogenic mass on the
left side of the fundus. There was neither ﬂuid in the Douglas
pouch, nor adnexal masses nor “ring of ﬁre” signs. Human chori-
onic gonadotropin (hCG) was  at 6320 mUI/ml. These ﬁndings
were consistent with ectopic interstitial pregnancy. According to
the department’s protocol, the patient received a single dose of
methotrexate.4 hCG decreased to 3010 mUI/ml after one week,
then raised to 7020 mUI/ml two weeks later. Therefore, the patient
underwent a laparoscopy. A 3 cm mass located on the left side
of the uterine fundus was found. The fallopian tubes and ovaries
were normal. The mass with portion of myometrium and serosa
were excised. Histological examination showed a hemorrhagic
inﬁltration of the myometrium without trophoblastic cells. Thus,
ssociates Ltd. This is an open access article under the CC BY-NC-ND license
 –  O
7 l of Su
a
n
p
a
i
s
p
e
l
a
w
m
n
t
p
M
ﬁ
w
3
p
p
m
w
i
a
r
t
m
i
1
t
a
d
s
b
l
c
i
d
t
c
c
ﬁ
m
f
w
l
n
t
c
O
T
p
cCASE  REPORT
88 S. Meddeb et al. / International Journa
 monthly monitoring of plasmatic hCG level was decided till its
egativity. However, earlier to her ﬁrst appointment, the patient
resented in the emergency room with severe acute pelvic pain
nd vaginal bleeding. Ultra sonography revealed a hyper echoic
ntrauterine mass and hCG titer was very high (4,000,000 mUI/ml)
uggestive for a persistent trophoblastic disease. Promptly, our
atient had unstable hemodynamic status, so she underwent
mergency hysterectomy. Histological examination revealed a pro-
iferation of atypical trophoblastic cells, both syncytiotrophoblastic
nd cytotrophoblastic cells with numerous mitoses. The stroma
as hemorrhagic and the tumor cells inﬁltration is limited to the
yometrial wall. There were no placental villi. Thus, the diag-
osis of choriocarcinoma was proposed. Imaging investigation of
he chest, abdomen and pelvis did not show any metastasis. The
atient was treated with 3 cycles of monochemotherapy based on
ethotrexate. The patient was followed by hCG test weekly in the
rst month, then monthly during the ﬁrst year. Two years later, she
as free from recurrence and metastasis.
. Discussion
Choriocarcinoma is a highly malignant tumor originating in tro-
hoblastic tissue. Usually presents within a hydatidiform mole, it
rimarily occurs during the procreation period.1 It is a biphasic
alignant proliferation of cytotrophoblast and syncytiotrophoblast
ithout chorial villi. The age has consistently been identiﬁed as an
mportant risk factor. Age-speciﬁc incidence reports usually reveal
 “J curve” and younger <18 year old and women >40 have higher
ates.5
Although the tumor may  arise from any type of prior gesta-
ional events as normal pregnancy or spontaneous abortion, it
ore frequently complicates hydatidiform mole regardless of its
ntrauterine or ectopic location.6
The development of the tumor varies between 5 weeks and
5 years after gestation or even after menopause.6,7 Its associa-
ion with ectopic pregnancy is extremely rare and in general with
ggressive behavior. Indeed, only 0.76–4% of choriocarcinomas
eveloped in ectopic location.8,9 Its speciﬁc occurrence in inter-
titial pregnancy is exceptional with, in our knowledge, three cases
eing reported in the literature including the present one.2,3
The diagnosis of primary extra-uterine choriocarcinoma is chal-
enging because the clinical symptoms are often nonspeciﬁc and
an mimic  hemorrhagic ovarian cyst, tubo-ovarian abscess, ovar-
an torsion, and ectopic pregnancy.10 The frequency of metastatic
isease with resultant increased morbidity and mortality is related
o the delayed diagnosis.
The typical sonographic appearance of intra-uterine choriocar-
inoma is a large echogenic irregular mass occupying the uterine
avity, hyper vascularized in color-ﬂow doppler. However, imaging
ndings are not helpful in extra-uterine location. Serial measure-
ent of hCG level was the most useful marker of diagnosis and
ollow up.11
When nonmetastatic choriocarcinoma occurs in young patients
ho desire to preserve their fertility, it should be treated byocal resection of the tumor followed by chemotherapy.3 At the
ew England trophoblastic disease center, all the women with
ubal choriocarcinoma (6/6) achieved complete remission with
hemotherapy even those with metastases (4/6).9 The two cases
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of choriocarcinoma arising in an interstitial pregnancy reported
were also successfully treated with chemotherapy based on
methotrexate.2,3
4. Conclusion
The increasing tendency to treat ectopic pregnancy by con-
servative management suggests the crucial role of pathological
examination associated with hCG level follow up, not only to
diagnose persistent ectopic pregnancy but also to avoid missing
malignant trophoblastic disease.
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